Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

These PR's cost money and lots of it

While informative, and greatly appreciated, these are not really new news, and/or they are not the giant steps forward in revenue recognition, deal making, or KOL partnerships that are so sorely needed by AMBS.

Eltopra going back to trials will require funding. ESS was declared the 'low hanging fruit' before the financial abortion put AMBS shareholders in the poor house and we were slotted for US Army base burn victim test trial at 3 bases - and we are now only focusing on identifying new cGMP manufacturer?

I applaud AMBS capital restructuring efforts and attempt to regain its financial footing. Gerald aided by the help of Spence are attempting to uplist. While that too is a huge positive, I suspect it will come at a significant RS in order to attain the $2.00 or $3.00 pps for the NasDaq - plus all other financial requirements, updated financial filings and necessary cash on hand to fulfill that obligation. With 120-Mil. OS and 150-Mil. AS, were in tight quarters.

Will the 'uplisting from strength' of old which decimated the shareholder community and brought pain and suffering be the new spin to make those who have averaged down the kingpin for the new uplisting?

AJMHO